Literature DB >> 7512028

B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40.

C van Kooten1, C Gaillard, J P Galizzi, P Hermann, F Fossiez, J Banchereau, D Blanchard.   

Abstract

The expression of CD40 ligand (CD40L) on activated T cells (CD4+ T cell clone MT9) is diminished when the T cells are cultured in the presence of B cells. This effect, observed both with normal tonsil B cells and with the B cell line JY, was detected after 6 h and sustained at least until 18 h of co-culture. Analysis of mRNA showed that CD40L mRNA levels were not modified after 6 h, but were significantly down-regulated after 18 h of co-culture with B cells. Although CD40L expression could not be detected by a CD40-Fc chimera, the molecule was still expressed at the membrane as shown with a polyclonal antiserum against CD40L (anti-TRAP). In addition, T cells activated in the presence of B cells were stained by a polyclonal antiserum against CD40, without the appearance of CD40 mRNA. These results indicated that a soluble form of CD40 (sCD40) bound to the expressed CD40L on T cells. The existence of sCD40 was confirmed by detection of sCD40 in B cell supernatants using a specific enzyme-linked immunosorbent assay. Collectively, these data show that B cells can regulate the expression of CD40L on activated T cells at least by two different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512028     DOI: 10.1002/eji.1830240402

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

1.  Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients.

Authors:  Cécile Contin; Vincent Pitard; Yahsou Delmas; Nadège Pelletier; Thierry Defrance; Jean-François Moreau; Pierre Merville; Julie Déchanet-Merville
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

2.  CD40L expression permits CD8+ T cells to execute immunologic helper functions.

Authors:  Marco Frentsch; Regina Stark; Nadine Matzmohr; Sarah Meier; Sibel Durlanik; Axel R Schulz; Ulrik Stervbo; Karsten Jürchott; Friedemann Gebhardt; Guido Heine; Morgan A Reuter; Michael R Betts; Dirk Busch; Andreas Thiel
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

3.  Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival.

Authors:  Robin Lesley; Lisa M Kelly; Ying Xu; Jason G Cyster
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-30       Impact factor: 11.205

4.  Locomotor properties of human germinal centre B cells: activation by anti-CD40 and IL-4 allows chemoattraction by anti-immunoglobulin.

Authors:  M Komai-Koma; P C Wilkinson
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

5.  Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.

Authors:  Mehdi Najar; Hussein Fayyad-Kazan; Wissam H Faour; Makram Merimi; Etienne M Sokal; Catherine A Lombard; Hassan Fahmi
Journal:  Inflamm Res       Date:  2018-11-30       Impact factor: 4.575

6.  A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Authors:  Marianne Delville; Tara K Sigdel; Changli Wei; Jing Li; Szu-Chuan Hsieh; Alessia Fornoni; George W Burke; Patrick Bruneval; Maarten Naesens; Annette Jackson; Nada Alachkar; Guillaume Canaud; Christophe Legendre; Dany Anglicheau; Jochen Reiser; Minnie M Sarwal
Journal:  Sci Transl Med       Date:  2014-10-01       Impact factor: 17.956

7.  Antibody production in autoimmune BXSB mice. I. CD40L-expressing B cells need fewer signals for polyclonal antibody synthesis.

Authors:  S Blossom; K M Gilbert
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

8.  A functional TNFRSF5 gene variant is associated with risk of lymphoma.

Authors:  Christine F Skibola; Alexandra Nieters; Paige M Bracci; John D Curry; Luz Agana; Danica R Skibola; Alan Hubbard; Nikolaus Becker; Martyn T Smith; Elizabeth A Holly
Journal:  Blood       Date:  2008-02-20       Impact factor: 22.113

Review 9.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

10.  Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

Authors:  A Desai-Mehta; L Lu; R Ramsey-Goldman; S K Datta
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.